Stay updated on Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a new Locations section with Texas as a listed site. Removed the old Texas Locations heading and the HHS Vulnerability Disclosure footer link; the page revision will now show as v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:09:22.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0; the update appears to be a minor frontend/backend change that does not alter the study information.
    Difference
    0.0%
    Check dated 2025-11-25T11:20:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - Added a new 'Last Update Posted (Estimated)' timestamp (2025-11-07) on the Study Details page. - Removed the site-wide government funding status notice.
    Difference
    0.5%
    Check dated 2025-11-18T07:10:59.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page shows routine timestamp updates in November 2025 and deletions from May 2025, with no substantive changes to the study design, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-11T02:53:20.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The new screenshot shows only cosmetic layout adjustments and a recent timestamp update; no changes to the study design, eligibility criteria, endpoints, or listed interventions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:06:06.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Upgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T05:40:46.000Z thumbnail image

Stay in the know with updates to Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.